全文获取类型
收费全文 | 71750篇 |
免费 | 4845篇 |
国内免费 | 201篇 |
专业分类
耳鼻咽喉 | 529篇 |
儿科学 | 2091篇 |
妇产科学 | 1166篇 |
基础医学 | 9832篇 |
口腔科学 | 1505篇 |
临床医学 | 7523篇 |
内科学 | 15209篇 |
皮肤病学 | 981篇 |
神经病学 | 6823篇 |
特种医学 | 2227篇 |
外国民族医学 | 1篇 |
外科学 | 10043篇 |
综合类 | 878篇 |
一般理论 | 72篇 |
预防医学 | 6392篇 |
眼科学 | 1737篇 |
药学 | 4906篇 |
1篇 | |
中国医学 | 80篇 |
肿瘤学 | 4800篇 |
出版年
2023年 | 376篇 |
2022年 | 521篇 |
2021年 | 1397篇 |
2020年 | 839篇 |
2019年 | 1364篇 |
2018年 | 1659篇 |
2017年 | 1237篇 |
2016年 | 1356篇 |
2015年 | 1582篇 |
2014年 | 2366篇 |
2013年 | 3210篇 |
2012年 | 5236篇 |
2011年 | 5367篇 |
2010年 | 3001篇 |
2009年 | 2666篇 |
2008年 | 4873篇 |
2007年 | 5332篇 |
2006年 | 5237篇 |
2005年 | 4969篇 |
2004年 | 4765篇 |
2003年 | 4309篇 |
2002年 | 4204篇 |
2001年 | 573篇 |
2000年 | 403篇 |
1999年 | 634篇 |
1998年 | 899篇 |
1997年 | 754篇 |
1996年 | 634篇 |
1995年 | 605篇 |
1994年 | 490篇 |
1993年 | 464篇 |
1992年 | 347篇 |
1991年 | 304篇 |
1990年 | 256篇 |
1989年 | 246篇 |
1988年 | 261篇 |
1987年 | 213篇 |
1986年 | 231篇 |
1985年 | 240篇 |
1984年 | 308篇 |
1983年 | 324篇 |
1982年 | 384篇 |
1981年 | 369篇 |
1980年 | 343篇 |
1979年 | 197篇 |
1978年 | 239篇 |
1977年 | 191篇 |
1976年 | 133篇 |
1975年 | 102篇 |
1974年 | 105篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
Background : A retrospective analysis of 103 case records from 1978 to 1996 with a provisional diagnosis of Buerger's disease was undertaken at the Department of Surgery, University of Hong Kong, Queen Mary Hospital. The aim of the study was to elucidate the clinical course and evaluate the results of surgical intervention of Buerger's disease in Hong Kong Chinese people. Methods : Fourteen patients were subsequently excluded from the study because of inability to fulfil our diagnostic criteria. Data on clinical presentation, investigations, indications and results of surgical intervention were reviewed. Sympathectomies and arterial reconstructions were performed on 42 and four patients, respectively, for critical ischaemia or rest pain. Outcome was analysed with respect to the rate of ulcer healing, pattern of recurrence and limb loss. Results : The patients were all young male heavy smokers with a mean age of 36.5 years. The majority of patients (80%) presented with ischaemic ulceration or gangrene. Vascular reconstruction was undertaken in four patients and satisfactory long-term results were obtained in three patients. Sympathectomy was able to relieve symptoms in 87% of operated patients and ischaemic ulceration healed in 2.6 (mean) ± 1.7 (SD) months after the operation. If the patient continued to smoke, surgical intervention did not exempt the patient from a relapse or amputation. Conclusion : Sympathectomy provides short-term pain relief and promotes ulcer healing in patients with Buerger's disease but carries no long-term benefit. Complete abstinence from smoking is the only means of arresting the progression of the disease. 相似文献
112.
Annette Jackson Cynthia McSherry Kim Butters Michael Diko P.Stephen Almond Arthur J Matas Nancy L Reinsmoen 《Human immunology》1997,55(2):148-153
Our previous studies have shown that the in vitro assay of donor antigen-specific hyporeactivity is a useful marker for identifying solid organ transplant recipients (kidney, lung and heart) at low risk for immunologic complications (i.e., late acute rejection episodes and chronic rejection). Donor antigen-specific hyporeactivity is defined as a significantly decreased post- vs. pretransplant proliferative response to donor antigens while response to third-party controls remains unchanged. We analyzed whether exposure to the same HLA-DR antigen pretransplant via random blood transfusion and posttransplant via the transplanted organ influenced the development of hyporeactivity. Thirty previously nontransfused recipients, each receiving two 150 ml pretransplant random blood transfusions, were assessed for hyporeactivity at 1 year posttransplant. Of the 12 recipients with pretransplant exposure to kidney HLA-DR via transfusions, 6 (50%) developed hyporesponsiveness; in contrast, of the 18 recipients who were not preexposed, only 3 (15%) exhibited this form of immunomodulation. Of interest, 2 of the 3 hyporesponsive recipients who were not preexposed, received units containing HLA-DR antigens previously shown to share crossreactive epitopes with the kidney HLA-DR. In conclusion, these results suggest a increased incidence in the development of hyporeactivity in patients receiving pretransplant transfusions which share an HLA-DR antigen with the transplanted kidney. 相似文献
113.
114.
Francisco M. Averhoff Walter W. Williams Stephen C. Hadler 《The Journal of school health》1997,67(7):298-303
SUMMARY: This report concerning the immunization of adolescents (ie, persons 11–21 years of age, as defined by the American Medical Association [AMA] and the American Academy of Pediatrics [AAP]) is a supplement to previous publications (ie, MMWR 1994;43[No. RR-1] 1–38; the AAP 1994 Red Book: Report of the Committee on Infectious Diseases; Summary of Policy Recommendations for Periodic Health Examination, August 1996 from the American Academy of Family Physicians [AAFP]; and AMA Guidelines for Adolescent Preventive Services [GAPS]: Recommendations and Rationale). This report presents a new strategy to improve the delivery of vaccination services to adolescents and to integrate recommendations for vaccination with other preventive services provided to adolescents. This new strategy emphasizes vaccination of adolescents 11–12 years of age by establishing a routine visit to their health-care providers. Specifically, the purposes of this visit are to a) vaccinate adolescents who have not been previously vaccinated with varicella virus vaccine, hepatitis B vaccine, or the second dose of the measles, mumps, and rubella (MMR) vaccine; b) provide a booster dose of tetanus and diphtheria toxoids; c) administer other vaccines that may be recommended for certain adolescents; and d) provide other recommended preventive services. The recommendations for vaccination of adolescents are based on new or current information for each vaccine. The most recent recommendations from AC1P, AAP, AAFP, and AMA concerning specific vaccines and delivery of preventive services should be consulted for details. 相似文献
115.
116.
117.
118.
119.
Azra M. Sehic Lillian W. Gaber Shane Roy III Paula M. Miller Stephen B. Kritchevsky Robert J. Wyatt 《Pediatric nephrology (Berlin, Germany)》1997,11(4):435-437
Based upon the percentage of cases of IgA nephropathy (IgAN) in biopsy series, a lower prevalence has been assumed for African-Americans
compared with Americans of European descent. This may be due to a racial difference in the basic underlying pathology of IgAN
or to racial differences in patterns of referral and biopsy selection practices. Over the past decade (1985 – 1994), we have
found similar incidences of IgAN in Caucasian and African-American children from Shelby County, Tennessee. The incidence was
3.0 cases per million per year for Caucasian and 5.7 cases per million per year for African-American children. IgAN may be
more common in African-American children than previously appreciated. Population-based incidence studies will be necessary
to determine whether or not our experience has become a more widespread phenomenon.
Received August 21, 1996; received in revised form and accepted December 18, 1996 相似文献
120.
Ronald G. Pratt Jie Zheng Brent K. Stewart Yoseph Shiferaw Anthony J. McGoron Ranasinghage C. Samaratunga Stephen R. Thomas 《Magnetic resonance in medicine》1997,37(2):307-313
A limited flip angle gradient-echo 3D volume acquisition imaging protocol for mapping partial pressure of oxygen (pO2) in perfluorocarbon compounds (PFCs) at low field (0.14 T) is presented. The pO2 measurement method is based on the paramagnetic effect of dissolved molecular oxygen (O2) which reduces the PFC 19F T1? Specific objectives related to imaging of PFCs through use of the protocol include improved image signal-to-noise characteristics and elimination of 19F chemical shift artifacts. A parametric Wiener deconvolution filtering algorithm is used for suppression of 19F chemical shift artifacts. Application of the protocol is illustrated in a series of calculated pO2 maps of a gas equilibrated, multi-chamber phantom containing perfluorotributylamine (FC-43). The utility of the protocol is demonstrated in vivo through images of a commercially available perfluorocarbon based blood substitute emulsion containing FC-43 sequestered in the liver and spleen of a rat. 相似文献